ASSET PURCHASE AGREEMENT by and between AMAG PHARMACEUTICALS, INC. and MILLICENT PHARMA LIMITED May 21, 2020Asset Purchase Agreement • May 22nd, 2020 • Amag Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of May 21, 2020, is made by and between Millicent Pharma Limited, a company organized under the laws of Ireland (the “Purchaser”), and AMAG Pharmaceuticals, Inc., a Delaware corporation (the “Seller”). Capitalized terms used and not otherwise defined herein have the meanings set forth in Article XI. In this Agreement, the Seller and the Purchaser are individually referred to as a “Party” and collectively as the “Parties.”
